Markers for Early Detection of Cardiac Diseases
Author:
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 65 (sup240) , 112-121
Abstract
The existing markers for myocardial necrosis, such as cardiac troponin, creatine kinase‐MB, and myoglobin are thought to be released into blood following irreversible myocardial necrosis. Thus results of these tests are usually negative for patients with acute coronary syndromes (ACS) who present to the emergency department (ED) within the first 3 hours after the onset of chest pain. Given the need to make early therapeutic and triage decisions, biomarkers that can be used to diagnose and/or risk stratify ACS patients during their initial ED presentation will be important. Active research in this area has identified several classes of biomarkers that show promise for early detection of disease. These include tests for the presence of acute inflammation and infiltration (e.g., high sensitivity‐C‐reactive protein, myeloperoxidase), plaque instability (e.g., pregnancy‐associated plasma protein‐A, placental growth factor), platelet activation (e.g., whole blood choline, platelet density, CD40 ligand), and myocardial ischemia (e.g., ischemia modified albumin, free fatty acids, serum choline, and B‐type natriuretic peptide). Each of these tests has demonstrated some utility for early diagnosis. However, as most lack specificity for myocardial disease, routine use may require a multi‐marker approach.Keywords
This publication has 27 references indexed in Scilit:
- Pregnancy-Associated Plasma Protein A and Its Endogenous Inhibitor, the Proform of Eosinophil Major Basic Protein (proMBP), Are Related to Complex Stenosis Morphology in Patients With Stable Angina PectorisCirculation, 2004
- National Heart, Lung, and Blood Institute Clinical Proteomics Working Group ReportCirculation, 2004
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I ElevationCirculation, 2003
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary SyndromesNew England Journal of Medicine, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- Independent Prognostic Value of Elevated C-Reactive Protein in Unstable AnginaCirculation, 1999
- Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemiaJACC, 1996
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994